Reviva Pharmaceuticals Holdings, Inc. (RVPH)
OTCMKTS · Delayed Price · Currency is USD
0.3521
0.00 (0.00%)
At close: May 14, 2026
RVPH Market Cap
RVPH has a market cap or net worth of $4.51 million as of May 14, 2026. Its market cap has decreased by -89.00% in one year.
Market Cap
4.51M
Enterprise Value
-9.52M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.35
Market Cap Chart
Since October 18, 2018, RVPH's market cap has decreased from 25.21M to 4.51M, a decrease of -82.11%. That is a compound annual growth rate of -20.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 4.51M | -86.16% |
| Dec 31, 2025 | 32.60M | -61.33% |
| Dec 31, 2024 | 84.31M | -41.36% |
| Dec 29, 2023 | 143.78M | 65.49% |
| Dec 30, 2022 | 86.88M | 115.01% |
| Dec 31, 2021 | 40.41M | -49.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nymox Pharmaceutical | 6.67M |
| Adaptimmune Therapeutics | 5.30M |
| Mosaic ImmunoEngineering | 5.03M |
| AccuStem Sciences | 4.19M |
| GPL Holdings | 4.17M |
| Bioxytran | 3.66M |
| Institute of Biomedical Research | 3.57M |
| CASI Pharmaceuticals | 2.98M |